Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Budget, Health, Industry, Research and Development, Science and Technology
|
Advance client's proposal to secure longer term funding to improve the health of Canadians by advancing promising discoveries to a commercially attractive stage and to build a collaborative research infrastructure to increase research and development capacity in the life sciences in Canada.
|
Grant, Contribution or Other Financial Benefit
|
End date of the last completed financial year: 2024-03-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Government of Quebec | $195,000.00 | Yes |
Innovation, Science and Economic Development Canada (ISED) | $27,000,000.00 | Yes |
Address:
4th Floor - 2405 Wesbrook Mall
Vancouver, BC V6T 1Z3
Canada
Telephone number:
604-827-1147
Fax number:
604-827-1299
Web address:
https://www.admarebio.com/
Gordon McCauley, President & CEO
adMare BioInnovations is not a subsidiary of any other parent companies.
adMare BioInnovations is not a coalition.
The activities of adMare BioInnovations are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
adMare BioInnovations does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
DANIEL BERNIER | Public offices held
Firm: Earnscliffe Strategy Group